BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18937192)

  • 1. [Multimodal therapy of esophageal cancer].
    Hartwig W; Strobel O; Lordick F; Büchler MW; Werner J
    Z Gastroenterol; 2008 Oct; 46(10):1207-13. PubMed ID: 18937192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal treatment of oesophageal carcinoma.
    Iizuka T
    Ann Chir Gynaecol; 1995; 84(2):216-21. PubMed ID: 7574383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent changes and the future roles of esophageal cancer surgery.
    Nishimaki T; Shimoji H; Sunagawa H
    Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):324-32. PubMed ID: 15658903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal therapy for squamous carcinoma of the oesophagus.
    Lehnert T
    Br J Surg; 1999 Jun; 86(6):727-39. PubMed ID: 10383570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
    Veuillez V; Rougier P; Seitz JF
    Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radio- and chemotherapy of cancer of the esophagus].
    Tiret E
    Rev Prat; 1999 Jun; 49(11):1186-91. PubMed ID: 10416350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer--do we need another randomised trial?
    Hingorani M; Crosby T; Maraveyas A; Dixit S; Bateman A; Roy R
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):696-705. PubMed ID: 21684129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy.
    Reynolds JV; Ravi N; Hollywood D; Kennedy MJ; Rowley S; Ryan A; Hughes N; Carey M; Byrne P
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):549-55. PubMed ID: 16935109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities.
    Mariette C; Piessen G; Triboulet JP
    Lancet Oncol; 2007 Jun; 8(6):545-53. PubMed ID: 17540306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant therapy for esophageal cancer: surgical considerations.
    Piraino A; Vita ML; Tessitore A; Cusumano G; Congedo MT; Margaritora S; Porziella V; Meacci E; Cesario A; Granone P
    Rays; 2006; 31(1):37-45. PubMed ID: 16999374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
    Shinoda M; Hatooka S; Mori S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
    Siersema PD; van Hillegersberg R
    Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of radiotherapy in the multimodal management of esophageal cancer.
    Fokas E; Weiss C; Rödel C
    Dig Dis; 2013; 31(1):30-7. PubMed ID: 23797120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.
    Gebski V; Burmeister B; Smithers BM; Foo K; Zalcberg J; Simes J;
    Lancet Oncol; 2007 Mar; 8(3):226-34. PubMed ID: 17329193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Section IV: selective use of neoadjuvant therapy.
    Kukreja J; Jaklitsch MT
    Semin Thorac Cardiovasc Surg; 2003 Apr; 15(2):187-96. PubMed ID: 12838489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.